Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Kahn

Showing results (961-970 of 1,385) with videos related to

Pageof 139
Sort By:
ACS Nano|April 9, 2019
Light-Induced Reversible DNA Ligation of Gold Nanoparticle SuperlatticesAngela F De Fazio, Afaf H El-Sagheer, Jason S Kahn, et al.
Journal of Psychopharmacology (Oxford, England)|February 10, 2010
Central nervous system effects of haloperidol on THC in healthy male volunteersMarieke Liem-Moolenaar, Erik T te Beek, Marieke L de Kam, et al.
Schizophrenia Research|April 28, 2010
Schizophrenia risk factors constitute general risk factors for psychiatric symptoms in the populationElemi J Breetvelt, Marco P M Boks, Mattijs E Numans, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|December 6, 2008
Psychosis and brain volume changes during the first five years of schizophreniaW Cahn, M Rais, F P Stigter, et al.
Psychiatry Research|February 25, 2023
Clinical features of individuals with schizotypal personality disorder with and without suicidal ideationLeo Sher, Katelyn N Challman, Emma C Smith, et al.
Schizophrenia Bulletin|March 31, 2023
Cannabis Use and Symptomatic Relapse in First Episode Schizophrenia: Trigger or Consequence? Data From the OPTIMISE StudyLinda Levi, Mor Bar-Haim, Inge Winter-van Rossum, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|September 25, 2010
Cannabis use and progressive cortical thickness loss in areas rich in CB1 receptors during the first five years of schizophreniaMonica Rais, Neeltje E M van Haren, Wiepke Cahn, et al.
Psychological Medicine|June 1, 2006
Saccadic abnormalities in psychotropic-naive obsessive-compulsive disorder without co-morbidityNic J van der Wee, Hans H Hardeman, Nick F Ramsey, et al.
Human Brain Mapping|November 24, 2011
Aberrations in the arcuate fasciculus are associated with auditory verbal hallucinations in psychotic and in non-psychotic individualsAntoin D de Weijer, Sebastiaan F W Neggers, Kelly M S Diederen, et al.
Schizophrenia Research|May 20, 2021
A phase 3, multicenter study to assess the 1-year safety and tolerability of a combination of olanzapine and samidorphan in patients with schizophrenia: Results from the ENLIGHTEN-2 long-term extensionRené S Kahn, Bernard L Silverman, Lauren DiPetrillo, et al.
Pageof 139

Showing results (961-970 of 1,385) with videos related to

Sort By:
Pageof 139
ACS Nano|April 9, 2019
Light-Induced Reversible DNA Ligation of Gold Nanoparticle SuperlatticesAngela F De Fazio, Afaf H El-Sagheer, Jason S Kahn, et al.
Journal of Psychopharmacology (Oxford, England)|February 10, 2010
Central nervous system effects of haloperidol on THC in healthy male volunteersMarieke Liem-Moolenaar, Erik T te Beek, Marieke L de Kam, et al.
Schizophrenia Research|April 28, 2010
Schizophrenia risk factors constitute general risk factors for psychiatric symptoms in the populationElemi J Breetvelt, Marco P M Boks, Mattijs E Numans, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|December 6, 2008
Psychosis and brain volume changes during the first five years of schizophreniaW Cahn, M Rais, F P Stigter, et al.
Psychiatry Research|February 25, 2023
Clinical features of individuals with schizotypal personality disorder with and without suicidal ideationLeo Sher, Katelyn N Challman, Emma C Smith, et al.
Schizophrenia Bulletin|March 31, 2023
Cannabis Use and Symptomatic Relapse in First Episode Schizophrenia: Trigger or Consequence? Data From the OPTIMISE StudyLinda Levi, Mor Bar-Haim, Inge Winter-van Rossum, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|September 25, 2010
Cannabis use and progressive cortical thickness loss in areas rich in CB1 receptors during the first five years of schizophreniaMonica Rais, Neeltje E M van Haren, Wiepke Cahn, et al.
Psychological Medicine|June 1, 2006
Saccadic abnormalities in psychotropic-naive obsessive-compulsive disorder without co-morbidityNic J van der Wee, Hans H Hardeman, Nick F Ramsey, et al.
Human Brain Mapping|November 24, 2011
Aberrations in the arcuate fasciculus are associated with auditory verbal hallucinations in psychotic and in non-psychotic individualsAntoin D de Weijer, Sebastiaan F W Neggers, Kelly M S Diederen, et al.
Schizophrenia Research|May 20, 2021
A phase 3, multicenter study to assess the 1-year safety and tolerability of a combination of olanzapine and samidorphan in patients with schizophrenia: Results from the ENLIGHTEN-2 long-term extensionRené S Kahn, Bernard L Silverman, Lauren DiPetrillo, et al.
Pageof 139